Alteration of intrahepatic microcirculation in cirrhotic livers
Authors:
- 1 August 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 78 (8) , 430-437
Abstract
From a hemodynamic point of view, hepatic vascular resistance and portal inflow determine the level of portal pressure. Factors that determine hepatic vascular resistance include both structural and dynamic components. Among the structural components are histological characteristics such as steatosis, fibrosis, regeneration nodules, and neo-angiogenesis. Dynamic structures include cells with contractile properties such as hepatocytes, hepatic stellate cells, sinusoidal endothelial cells, and Kupffer cells. The contributions of the interactions between four cells in cirrhotic livers resulted in hepatic endothelial dysfunction, hepatic microcirculatory dysfunction, hepatic venous dysregulation, hepatic fibrogenesis, and subsequently increased intrahepatic resistance and portal hypertension in cirrhosis. The pathogenic mechanisms that trigger the associated abnormalities in hepatic microcirculations include persistent endotoxemia, increased hepatic oxidative stress, activated endocannabinoids substances, pathogenic sinusoidal remodeling, and hypoperfusion in cirrhotic livers. Cumulative data suggested that various therapeutic strategies targeting hepatic microcirculation provided effective improvement of the systemic abnormalities of cirrhosis. Accordingly, the mechanistic and therapeutic approaches focusing on the disarrangement of hepatic microcirculation will be introduced in this article.Keywords
This publication has 75 references indexed in Scilit:
- Inflammation and portal hypertension – The undiscovered countryJournal of Hepatology, 2014
- Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive ratsJournal of Gastroenterology and Hepatology, 2014
- Anti‐VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH‐cirrhotic ratLiver International, 2013
- Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic ratsJournal of the Chinese Medical Association, 2012
- Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosisClinical Science, 2012
- Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic ratsHepatology, 2012
- The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and RepairPhysiological Reviews, 2009
- Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosisClinical Science, 2007
- Roles of anandamide in the hepatic microcirculation in cirrhotic ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Complications of cirrhosis. I. Portal hypertensionJournal of Hepatology, 2000